Answers are grounded in this paper and cite their sources.
Background: Although medically necessary hospital and physician services are publicly funded in Canada, cancer can still create substantial financial burden. We characterized patient- and household-level financial effects of cancer in Canada and populations at greater risk. Methods: We conducted a PRISMA-ScR scoping review with a prospectively registered OSF protocol. MEDLINE, Embase, Scopus, and PubMed were searched from inception to 18 June 2026, for Canadian studies reporting patient- or household-level financial outcomes. Results: Of 1012 records, 53 publications from 2004–2026 were included; 14 were primarily qualitative and 21 used national or multiprovincial samples. Financial toxicity spanned out-of-pocket, travel and accommodation costs, employment and income loss, caregiving demands, distress, and coping. Younger and lower-income patients were repeatedly identified as more vulnerable; geographic access, inadequate insurance or income protection, and caregiving responsibilities were also reported as sources of burden. Some publications analyzed overlapping cohorts, so the 53 publications do not represent 53 necessarily independent populations. Financial pressure was reported alongside changes in treatment, supportive care, and return-to-work decisions. Reported relationships with quality of life and clinical outcomes came from observational evidence; the clinical-outcome evidence was limited and does not establish causation. Conclusions: Publicly funded healthcare does not fully protect Canadian families from cancer-related financial consequences. Screening, income protection, travel assistance, and medication support are priorities for evaluation; this review did not establish their effectiveness.
No takes yet. Share an insight, caveat, or question.
Uy et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: